BriefTea
Every story in sixty words
Get the free app no ads · no paywallNews · 4 May 2026
Unsplash / CDC
The NHS has begun rolling out an injectable form of Keytruda, an immunotherapy drug previously given by IV drip lasting up to two hours. The new jab takes one to two minutes, cutting treatment time by up to 90 percent. Around 14,000 cancer patients in England start this therapy each year and most will benefit.
Reported by BBC · How we write briefs
More briefs
WorldMore Than 160 Arrested as Cost-of-Living Protests Sweep France BusinessBBC Pauses DIY SOS for 2027 to Save Money PoliticsHealey and Miliband Mocked Over Bangkok Tuk-Tuk Snack Video WorldPope Leo leaves hospital early following successful lung cancer surgery WorldDelegates walk out during Russian finance minister speech at IMF meeting TransportVW recalls thousands of electric cars over fire risk Browse all stories →We would like to count visits and see which links bring readers here. That means storing a random ID in your browser. No cookies, no ads, no profile. How it works.